Table 2.
Clinical Chemistry Characteristics of Study Participants
| All | Men | Women | |
|---|---|---|---|
| N | 12 313 | 5585 | 6728 |
| Glucose, mmol/L | 5.6 (±1.2) | 5.8 (±1.3) | 5.4 (±1.1) |
| Hba1c, % | 4.8 (±0.7) | 4.8 (±0.7) | 4.8 (±0.6) |
| LDL, mmol/L | 3.8 (±1.0) | 3.7 (±1.0) | 3.9 (±1.0) |
| HDL, mmol/L | 1.4 (±0.4) | 1.2 (±0.3) | 1.6 (±0.4) |
| Triglycerides, mmol/L | 1.3 (±0.8) | 1.4 (±0.9) | 1.3 (±0.7) |
| Total cholesterol, mmol/L | 5.8 (±1.1) | 5.5 (±1.1) | 6.0 (±1.1) |
| CRP, mg/L | 3.22 (±6.5) | 3.37 (±7.6) | 3.08 (±5.0) |
| Creatinine, μmol/L | 77.5 (±23.6) | 86.9 (±28.8) | 69.7 (±14.2) |
| Cystatin C, mg/L | 1.02 (±0.3) | 1.05 (±0.3) | 0.99 (±0.3) |
| Estimated GFR, MDRD* | 83.1 (±18.1) | 85.6 (±19.8) | 81.1 (±16.2) |
| eGFR CysC, mL/min per 1.73 m2* | 83.6 (±21.9) | 81.2 (±21.8) | 85.7 (±21.6) |
| CKD‐epi Crea, mL/min per 1.73 m2* | 86.1 (±16.0) | 92.9 (±15.5) | 80.4 (±14.0) |
| CKD‐epi CysC, mL/min per 1.73 m2* | 76.4 (±19.5) | 77.2 (±20.2) | 75.8 (±18.8) |
| CKD‐epi Crea+CysC, mL/min per 1.73 m2* | 77.4 (±16.0) | 76.8 (±16.2) | 77.9 (±15.9) |
All values are means±standard deviations. CKD indicates Chronic Kidney Disease; CRP, C‐Reactive Protein; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; MDRD, Modification of Diet in Renal Disease; N, number of participants, CKD indicates Chronic Kidney Disease.
*
GFR according to the MDRD formula.
*
Machine calculated GFR.
*
GFR according to the CKD‐epi formula.